top TOP
October 5, 2021

Yael Mardor, PhD

Chaim Sheba Medical Center

ICRF Acceleration Grant Recipient

ICRF is currently supporting nine projects in the area of breast cancer research. Meet one of the newly-funded researchers for 2021-2022 below:

Yael Mardor, PhD, a recipient of an ICRF Acceleration Grant at Chaim Sheba Medical Center, is researching breast cancer that has metastasized to the brain. Herceptin® is a drug that specifically targets breast cancer cells that carry high levels of the HER-2 protein. It can control breast cancer that has metastasized anywhere in the body except the brain, where the blood brain barrier (or BBB) inhibits access. The Mardor team has pioneered a safe and non-invasive approach for disrupting the BBB with short, repeated electrical field treatments, and will use this method to develop a platform that causes transient disruption of the BBB to permit efficient delivery of Herceptin® to the brain.

View Grant Recipient profile

Help End the Suffering Caused By Cancer

The answer to cancer is research. Support groundbreaking cancer research in Israel today: